News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. stocks closed higher as the Dow hit a record, led by tech and consumer goods while the VIX fell to a one-month low.
  • Vertex will buy Crinetics for about $10 billion in cash, with the deal expected to close in Q3.
  • Abivax closed a $920 million public offering to fund operations through late 2029.
  • Bulgaria and Turkey agreed to freeze long-term gas contract terms for 15 months, with Bulgaria paying only for used import capacity.
  • The U.S. Strategic Petroleum Reserve fell to 319.5 million barrels, its lowest level since 1983, after planned drawdowns.
  • Aligos signed a Greater China license for pevifoscorvir, received $25 million upfront and saw shares surge over 20% after-hours.

Latest Articles

Blackstone Affiliates Divest $28.2M in Bumble Stock Amid Strategic Shift

Blackstone Affiliates Divest $28.2M in Bumble Stock Amid Strategic Shift

Entities tied to Blackstone Inc. executed a substantial divestment of Bumble Inc. (NASDAQ:BMBL) Class A Common Stock, totaling approximately $28.2 million. This transaction, reported on June 16, 2026, involved the sale of 7,477,500 shares at an average price of $3.7751 per share. The disposition was facilitated through a hedging period associated w…

Blackstone Groups Liquidate $28.2M in Bumble Shares Amid Revenue Headwinds

Blackstone Groups Liquidate $28.2M in Bumble Shares Amid Revenue Headwinds

Blackstone-affiliated investment vehicles executed a coordinated divestment of 7,477,500 shares of Bumble Inc. (NASDAQ:BMBL) on June 16, 2026, realizing approximately $28.2 million in proceeds. These transactions occurred at a uniform price of $3.7751 per share, significantly above the stock's current trading level of $2.96. The sales reduce the co…

Klaviyo CFO Whalen Executes $185,220 Equity Sale Under Pre-Arranged Plan

Klaviyo CFO Whalen Executes $185,220 Equity Sale Under Pre-Arranged Plan

Klaviyo, Inc. (NYSE: KVYO) Chief Financial Officer Amanda Whalen has completed a significant equity transaction, selling 14,000 shares of the company's Series A Common Stock. Executed on June 18, 2026, the sale generated proceeds of $185,220, with shares transacting at prices between $13.12 and $13.49. The transaction was facilitated through a Rule…

Blackstone-Linked Entities Divest $28.2 Million in Bumble Stock

Blackstone-Linked Entities Divest $28.2 Million in Bumble Stock

Seven entities affiliated with Blackstone Inc. sold 7,477,500 shares of Bumble Inc. (NASDAQ:BMBL) on June 16, 2026, totaling approximately $28.2 million in value. The transactions occurred at $3.7751 per share, determined by a volume-weighted average price during a hedging period for a post-paid forward transaction. Following the sales, these entit…

BOJ Minutes Reveal Calls for Accelerated Rate Hikes Amid Geopolitical Concerns

BOJ Minutes Reveal Calls for Accelerated Rate Hikes Amid Geopolitical Concerns

Minutes from the Bank of Japan’s April policy meeting have revealed internal divisions among board members regarding the pace of monetary tightening. While the central bank maintained interest rates at their current level during the April session, several members advocated for a more aggressive approach to raising borrowing costs. The discussion hi…

Vaxcyte Executive Transaction Analysis

Vaxcyte Executive Transaction Analysis

Andrew Guggenhime, President and Chief Financial Officer of Vaxcyte, Inc., executed a sale of 10,000 shares on June 18, 2026, under a Rule 10b5-1 plan adopted in March. The transaction, valued at $530,000 at $53.00 per share, coincided with the exercise of stock options for an equal number of shares. This financial activity occurs against a backdro…

Vistra Director Executes $4 Million Share Sale Under Pre-Arranged Plan

Vistra Director Executes $4 Million Share Sale Under Pre-Arranged Plan

Vistra Corp. director Scott B. Helm executed a significant sale of company stock, divesting 25,000 shares valued at $4 million on June 16, 2026. The transaction was facilitated through a Rule 10b5-1 trading plan established earlier in the year, a mechanism designed to automate trading schedules and mitigate regulatory concerns regarding insider tim…

Fastly President Executes Stock Sale Amid Volatile Trading

Fastly President Executes Stock Sale Amid Volatile Trading

Scott R. Lovett, President of Go to Market at Fastly, Inc. (NASDAQ:FSLY), completed a transaction involving the sale of 34,919 shares of Class A Common Stock on June 16, 2026. The sale generated approximately $633,779, with shares transacted at prices between $17.83 and $18.16 per share. The transaction was executed to meet tax obligations associat…

Japan's Core Inflation Remains Below BOJ Target Amid Fuel Subsidy Effects

Japan's Core Inflation Remains Below BOJ Target Amid Fuel Subsidy Effects

Japan's annual core inflation rate held steady at 1.4% in May, marking the fourth consecutive month below the Bank of Japan's 2% target. Government figures indicate that fuel subsidies continue to offset rising raw material costs linked to the Middle East conflict. The data comes as the central bank recently raised interest rates to a 31-year high,…

Venture Global CFO Offloads $2.44M in Stock Amid Strategic Expansion

Venture Global CFO Offloads $2.44M in Stock Amid Strategic Expansion

Jonathan W Thayer, Chief Financial Officer of Venture Global (VG), executed a series of stock sales totaling $2,441,042 over June 17 and 18, 2026, as documented in a recent Form 4 filing. The transactions involved the sale of 222,222 Class A Common Stock shares at weighted average prices between $10.9175 and $11.0519 per share. These sales followed…

Nektar Therapeutics CEO Executes $1.2M Stock Sale Under Pre-Arranged Plan

Nektar Therapeutics CEO Executes $1.2M Stock Sale Under Pre-Arranged Plan

Robin Howard W, President and Chief Executive Officer of Nektar Therapeutics Inc., has completed a series of stock sales totaling approximately $1.215 million. The transactions were conducted over two days in mid-June 2026 under a Rule 10b5-1 trading plan established earlier in the year. The sales coincide with a period of significant price appreci…